Countervail Corporation


Israeli parent patent for the use of Galantamine and Antimuscarinic Agent For Organophosphorus Poisoning awarded.

The acceptance of the above-referenced application was published in the Israeli Patents and Designs Journal of January 31, 2016. With the volatile situation in the Middle East, patent protection in Israel of our technology for medical countermeasures against nerve agent exposure is an important accomplishment.